Sepsis Alliance Inspiring Breakthroughs in Care with New Virtual Conference: Sepsis Tech & Innovation
April 13, 2021
Across two days of expert-led content, Sepsis Tech & Innovation will examine the potential of technology and innovation to save lives and reduce sepsis spending.
Catapulting off the success of last year’s inaugural Sepsis Alliance Summit, Sepsis Alliance is pleased to announce a new virtual conference: Sepsis Tech & Innovation. Sepsis Tech & Innovation is an opportunity for Sepsis Alliance to expand its voice in the health innovation and technology space, with the ultimate goal of taking the costly guesswork out of sepsis diagnosis and care. The virtual conference will convene on June 22 and 23, 2021.
Sepsis is the #1 cause of death in U.S. hospitals (one in every three deaths) and also the #1 cost of hospitalizations in the United States ($52 billion/year). Additionally, sepsis is the leading cause of COVID-19 deaths. As many as 80% of lives lost to sepsis could be saved with rapid diagnosis and treatment; innovations that will be presented and discussed at Sepsis Tech & Innovation have the potential to make such efficient and life-saving sepsis detection possible. Learn more about the burden of sepsis here.
“As hospitals and organizations move towards integrating additional technology in all aspects of diagnosis, treatment, and care, it is important that technology for sepsis and post-sepsis syndrome does not get forgotten,” said Thomas Heymann, Sepsis Alliance President and CEO. “We are bringing together the leaders in tech, innovation, and sepsis for this conference and expect to make a huge impact towards saving lives and limbs from sepsis.”
The Sepsis Alliance Summit, Sepsis Alliance’s first foray into virtual conferences, attracted over 4,000 registrants and awarded thousands of nursing continuing education credit hours.
A diverse group of subject experts will present on varied facets of sepsis, antimicrobial resistance, health equity, and the technologies and innovations created to reduce their burden, including:
- Dr. Michelle McMurray-Heath, the President and CEO of Biotechnology Innovation Organization;
- Suchi Saria, the Founder and CEO of Bayesian Health, the John C. Malone Associate Professor of computer science, statistics, and health policy, and the Director of the Machine Learning and Healthcare Lab at Johns Hopkins University.
- Leroy Sims, the Medical Director of the National Basketball Association who managed last summer’s bio-secure bubble in Orlando, Florida;
- Tom Lawry, National Director of AI for Health & Life Sciences, Microsoft
To view additional speakers and the agenda, please click here.
To learn more and register for the event, please visit http://SepsisTech.org.
Sepsis Alliance would like to thank the following sponsors for their support of this event:
Sepsis Alliance
Sepsis Alliance, the first and leading sepsis organization in the U.S., seeks to save lives and reduce suffering by improving sepsis awareness and care. More than 1.7 million people are diagnosed with sepsis each year in the U.S. with more than 270,000 dying and over 50% of survivors experiencing post-sepsis syndrome and other lingering effects, including amputations. At Sepsis Alliance’s founding in 2003, only 19% of U.S. adults were aware of the term “sepsis.” After over ten years of educational efforts for the general public and healthcare providers through Sepsis.org, Sepsis Alliance Clinical Community, Sepsis Alliance Institute, and Sepsis Alliance Voices, awareness is at an all-time high of 71% with over 20,000 healthcare providers across the country having attended sepsis webinars and courses to elevate their practice and over 28 Sepsis Awareness Month state proclamations. Sepsis Alliance is a 501(c)3 nonprofit and a GuideStar Platinum Rated charity. For more information, please visit www.sepsis.org and connect with Sepsis Alliance on Facebook, Twitter, Instagram, and LinkedIn at @SepsisAlliance.
